Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin

JAAD Case Rep. 2023 Nov 1:42:78-83. doi: 10.1016/j.jdcr.2023.10.010. eCollection 2023 Dec.

Authors

Donglin Zhang¹, Kimberly Sable¹, Allison Miller¹, Molly Hinshaw¹, Timothy Schmidt², Bridget E Shields¹

Affiliations

¹ Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
² Department of Hematology and Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

No abstract available

Keywords: JAK inhibitor; cutaneous mucinosis; granulomatous scleromyxedema; sclerodermoid lichen myxedematosus; scleromyxedema.

Publication types

Case Reports